Clinical Trial Update: A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial studying Fluzoparib in combination with mFOLFIRINOX in advanced pancreatic cancer has completed Phase 1/2 enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Fluzoparib (fluzoparib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED